• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国上海癌症发病趋势预测:老龄化人口带来的负担。

Future of cancer incidence in Shanghai, China: Predicting the burden upon the ageing population.

机构信息

State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China; Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, China; Fudan University Taizhou Institute of Health Sciences, Taizhou, China.

State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China; Fudan University Taizhou Institute of Health Sciences, Taizhou, China.

出版信息

Cancer Epidemiol. 2019 Jun;60:8-15. doi: 10.1016/j.canep.2019.03.004. Epub 2019 Mar 14.

DOI:10.1016/j.canep.2019.03.004
PMID:30878799
Abstract

AIM

The age-specific cancer patterns have changed significantly over the last few decades in urban Shanghai. Predicting the cancer incidence in an ageing population can help to anticipate future resource needs, evaluate primary prevention strategies, and inform further research studies.

MATERIALS AND METHODS

Annual cancer cases and population data from 1988 to 2013 were collected from Shanghai Cancer Registry. A Bayesian age-period-cohort model was applied to project the future cancer incidence with demographical changes from 2014 to 2025.

RESULTS

From 1988 through 2013, the urban population aged < 65 years decreased by 19.5%, while the population aged ≥ 65 years increased by 58.4%. In the same period, cancer cases increased by 66.0% (from 8315 to 13,806) and 88.6% (from 7448 to 14,048) in these two populations, respectively. From 2014-2025, the population size is expected to decrease by an additional 29.6% in people aged < 65 years, while it will increase by an additional 68.3% in people aged ≥ 65 years. Correspondingly, the model predicts an 87.5% and 143.4% increase in cancer cases for these two populations, respectively. The most pronounced increase was found in thyroid cancer in both sexes, followed by prostate, kidney, and colon cancer in men. In women, lung, kidney, and cervical cancer in women was expected to increase.

CONCLUSIONS

The number of cancer cases in urban Shanghai, especially in older people, is expected to significantly increase in the next decade. Particular strategies targeting the elderly are required to combat the cancers.

摘要

目的

过去几十年中,上海市区的特定年龄癌症模式发生了显著变化。预测老龄化人口中的癌症发病率有助于预测未来的资源需求,评估初级预防策略,并为进一步的研究提供信息。

材料和方法

从上海癌症登记处收集了 1988 年至 2013 年的年度癌症病例和人口数据。应用贝叶斯年龄-时期-队列模型,根据人口变化预测 2014 年至 2025 年的未来癌症发病率。

结果

1988 年至 2013 年,年龄<65 岁的城市人口减少了 19.5%,而年龄≥65 岁的人口增加了 58.4%。同期,这两个年龄段的癌症病例分别增加了 66.0%(从 8315 例增加到 13806 例)和 88.6%(从 7448 例增加到 14048 例)。2014 年至 2025 年,年龄<65 岁的人口预计将减少 29.6%,而年龄≥65 岁的人口将增加 68.3%。相应地,该模型预测这两个年龄段的癌症病例将分别增加 87.5%和 143.4%。男女两性甲状腺癌的增幅最为显著,其次是前列腺癌、肾癌和结肠癌。在女性中,预计肺癌、肾癌和宫颈癌将增加。

结论

未来十年,上海市区的癌症病例数量,尤其是老年人的癌症病例数量预计将显著增加。需要针对老年人制定特定策略来防治癌症。

相似文献

1
Future of cancer incidence in Shanghai, China: Predicting the burden upon the ageing population.中国上海癌症发病趋势预测:老龄化人口带来的负担。
Cancer Epidemiol. 2019 Jun;60:8-15. doi: 10.1016/j.canep.2019.03.004. Epub 2019 Mar 14.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Projecting Cancer Incidence for 2025 in the 2 Largest Populated Cities in Vietnam.预测越南人口最多的两个城市 2025 年的癌症发病率。
Cancer Control. 2019 Jan-Dec;26(1):1073274819865274. doi: 10.1177/1073274819865274.
4
[Trend analysis and prediction of cancer incidence in China].[中国癌症发病率的趋势分析与预测]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):581-6.
5
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
6
Italian cancer figures, report 2013: Multiple tumours.《2013年意大利癌症数据报告:多发性肿瘤》
Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152.
7
[Report of cancer epidemiology in China, 2015].《2015年中国癌症流行病学报告》
Zhonghua Zhong Liu Za Zhi. 2019 Jan 23;41(1):19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005.
8
[Analysis and prediction of liver cancer incidence in China].[中国肝癌发病率的分析与预测]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):587-92.
9
The incidence and mortality of major cancers in China, 2012.2012年中国主要癌症的发病率和死亡率。
Chin J Cancer. 2016 Aug 2;35(1):73. doi: 10.1186/s40880-016-0137-8.
10
Disparities in Cancer Incidence among Chinese Population versus Migrants to Developed Regions: A Population-Based Comparative Study.中国人口与移民至发达地区人群的癌症发病率差异:基于人群的比较研究。
Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):890-899. doi: 10.1158/1055-9965.EPI-18-0827. Epub 2019 Apr 3.

引用本文的文献

1
The disease burden of kidney cancer in Asian countries and regions from 1990 to 2021: a study based on the Global Burden of Disease database.1990年至2021年亚洲国家和地区肾癌的疾病负担:一项基于全球疾病负担数据库的研究。
Transl Androl Urol. 2025 Apr 30;14(4):1049-1065. doi: 10.21037/tau-2024-652. Epub 2025 Apr 27.
2
Liquid biopsy of extracellular vesicle biomarkers for prostate cancer personalized treatment decision.用于前列腺癌个性化治疗决策的细胞外囊泡生物标志物的液体活检
Extracell Vesicles Circ Nucl Acids. 2022 Jan 13;3(1):3-9. doi: 10.20517/evcna.2021.20. eCollection 2022.
3
Lung cancer incidence and mortality in trend and prediction between 2012-2030 in Shandong Province, using a Bayesian age-period-cohort model.
利用贝叶斯年龄-时期-队列模型对山东省2012年至2030年肺癌发病率和死亡率的趋势及预测
Front Oncol. 2024 Dec 4;14:1451589. doi: 10.3389/fonc.2024.1451589. eCollection 2024.
4
Decomposing difference in the kidney cancer burden measures between 1990 and 2019 based on the global burden of disease study.基于全球疾病负担研究,分解 1990 年至 2019 年期间肾癌负担测量指标的差异。
Sci Rep. 2024 May 6;14(1):10390. doi: 10.1038/s41598-024-61300-2.
5
Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells.患者来源前列腺癌细胞的综合多组学和药物反应特征分析。
Signal Transduct Target Ther. 2023 May 1;8(1):175. doi: 10.1038/s41392-023-01393-9.
6
The relationship between serum albumin and prostate-specific antigen: A analysis of the National Health and Nutrition Examination Survey, 2003-2010.血清白蛋白与前列腺特异性抗原的关系:2003-2010 年全国健康与营养调查分析。
Front Public Health. 2023 Mar 6;11:1078280. doi: 10.3389/fpubh.2023.1078280. eCollection 2023.
7
Identification of potential biomarkers for papillary thyroid carcinoma by comprehensive bioinformatics analysis.综合生物信息学分析鉴定甲状腺乳头状癌的潜在生物标志物。
Mol Cell Biochem. 2023 Sep;478(9):2111-2123. doi: 10.1007/s11010-022-04606-x. Epub 2023 Jan 12.
8
Trends and predictions of lung cancer incidence in Jiangsu Province, China, 2009-2030: a bayesian age-period-cohort modelling study.中国江苏省 2009-2030 年肺癌发病率的趋势和预测:贝叶斯年龄-时期-队列模型研究。
BMC Cancer. 2022 Oct 31;22(1):1110. doi: 10.1186/s12885-022-10187-1.
9
Oncolyic Virotherapy for Prostate Cancer: Lighting a Fire in Winter.肿瘤溶瘤病毒疗法治疗前列腺癌:冬日里的一把火。
Int J Mol Sci. 2022 Oct 21;23(20):12647. doi: 10.3390/ijms232012647.
10
MRI radiomics predicts progression-free survival in prostate cancer.MRI影像组学可预测前列腺癌的无进展生存期。
Front Oncol. 2022 Aug 30;12:974257. doi: 10.3389/fonc.2022.974257. eCollection 2022.